BW

Bradley Jay Willenberg

CEO at Saisijin Biotech

Dr. Bradley Jay Willenberg, PhD has over ten years of experience in the fields of biomaterials and tissue engineering. He also has an extensive background in biology, biochemistry and synthetic organic chemistry. As primary developer and inventor of capillary-alginate biomaterials, Dr. Willenberg is the world’s expert on the technology. He is one of Saisijin’s co-founders and current Chief Executive Officer (CEO).

Timeline

  • CEO

    Current role